Drugs & TargetsFree FDA grants accelerated approval to nivolumab and ipilimumab combination for hepatocellular carcinoma March 13, 2020Vol.46 No.11
Drugs & TargetsFree FDA accepts BLA for biosimilar MYL-1402O in cancer indications March 13, 2020Vol.46 No.11
Drugs & TargetsFree FDA grants Breakthrough Therapy Designation for JNJ-6372 in NSCLC indication March 13, 2020Vol.46 No.11
Drugs & TargetsFree Thermo Fisher Scientific collaborates with Janssen to co-develop companion diagnostic for cancer March 13, 2020Vol.46 No.11
Drugs & TargetsFree European Commission approves Venclyxto in CLL indication March 13, 2020Vol.46 No.11
Drugs & Targets FDA approves Sarclisa in patients with previously treated MM March 06, 2020Vol.46 No.10
Drugs & Targets FDA grants RMAT designation for CD30 CAR-T cell therapy in Hodgkin lymphoma indication March 06, 2020Vol.46 No.10
Drugs & Targets FDA grants tipifarnib Fast Track designation in T-cell lymphomas March 06, 2020Vol.46 No.10
